MoonLake Immunotherapeutics
MLTX
$17.80
-$0.20-1.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.45% | -12.07% | -22.97% | -18.22% | -12.23% |
| Total Receivables | 92.87% | 71.20% | 67.09% | 103.30% | 99.75% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 42.39% | -2.40% | 67.13% | 75.19% | 359.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.65% | -11.09% | -19.73% | -15.16% | -8.55% |
|
|
|||||
| Total Current Assets | -21.65% | -11.09% | -19.73% | -15.16% | -8.55% |
| Net Property, Plant & Equipment | -27.61% | -41.19% | -33.91% | -24.54% | -21.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.85% | -- | -71.57% | -58.90% | -73.13% |
| Total Assets | -21.69% | -11.19% | -20.05% | -15.56% | -9.37% |
|
|
|||||
| Total Accounts Payable | 166,900.00% | 100.55% | 361.81% | 241.27% | -93.14% |
| Total Accrued Expenses | 0.57% | 111.11% | 150.98% | 144.84% | 219.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -35.75% | -10.06% | 3.74% | 17.27% | 9.78% |
| Total Finance Division Other Current Liabilities | -37.50% | 70.40% | 109.29% | 0.82% | 113.57% |
| Total Other Current Liabilities | -37.50% | 70.40% | 109.29% | 0.82% | 113.57% |
| Total Current Liabilities | 92.29% | 102.46% | 140.86% | 122.77% | 169.13% |
|
|
|||||
| Total Current Liabilities | 92.29% | 102.46% | 140.86% | 122.77% | 169.13% |
| Long-Term Debt | 35.60% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -24.26% | -74.35% | -74.89% | -58.66% | -51.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -34.14% | -- | -21.01% | 5.92% | 15.84% |
| Total Liabilities | 48.31% | 388.76% | 442.21% | 588.07% | 741.21% |
|
|
|||||
| Common Stock & APIC | 15.52% | 13.19% | 2.04% | 1.78% | 1.56% |
| Retained Earnings | -93.30% | -96.49% | -110.79% | -113.95% | -111.41% |
| Treasury Stock & Other | -86.51% | -87.91% | -90.19% | -84.03% | -11.37% |
| Total Common Equity | -37.67% | -31.86% | -40.82% | -32.06% | -24.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.67% | -31.86% | -40.82% | -32.06% | -24.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -68.73% | -55.03% | -48.53% |
| Total Equity | -38.43% | -32.84% | -41.23% | -32.47% | -25.31% |
|
|
|||||